Jim Simons Connect Biopharma Holdings LTD Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 143,700 shares of CNTB stock, worth $212,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
143,700
Previous 114,800
25.17%
Holding current value
$212,676
Previous $63,000
122.22%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CNTB
# of Institutions
20Shares Held
2.63MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN1.82MShares$2.7 Million1.35% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$238,0830.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$153,7580.0% of portfolio
-
Callan Capital, LLC La Jolla, CA80KShares$118,4000.0% of portfolio
-
Alpha Core Capital LLC La Jolla, CA80KShares$118,4000.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $81.4M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...